Pancreatic cancer: failures and hopes—a review of new promising treatment approaches
Pancreatic cancer is a challenging disease with limited treatment options and a high mortality rate. Just few therapy advances have been made in recent years. Tumor microenvironment, immunosuppressive features and mutational status represent important obstacles in the improvement of survival outcome...
Saved in:
| Main Authors: | Vittore Cereda, Mario Rosario D’Andrea |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-03-01
|
| Series: | Exploration of Targeted Anti-tumor Therapy |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A1002299/1002299.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer
by: Nawaz Khan, et al.
Published: (2025-07-01) -
Characterization of the Pancreatic Neuroendocrine Neoplasm Immune Microenvironment
by: Filipe Reis Neves, et al.
Published: (2025-04-01) -
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer
by: Carolin Schneider, et al.
Published: (2025-05-01) -
Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
by: Shenao Fu, et al.
Published: (2025-07-01) -
Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer
by: Ran Cui, et al.
Published: (2025-03-01)